Elevated Chlamydia pneumoniae Antibodies, Cardiovascular Events, and Azithromycin in Male Survivors of Myocardial Infarction
暂无分享,去创建一个
A. Camm | J. Kaski | D. Carrington | E. Leatham | M. Mendall | S. Gupta
[1] M L Woods,et al. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. , 1996, Journal of the American College of Cardiology.
[2] D. Strachan,et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors , 1995, BMJ.
[3] D. Stewart,et al. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. , 1995, The Journal of infectious diseases.
[4] D. Strachan,et al. Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. , 1995, The Journal of infection.
[5] D. Fanti,et al. Efficacy of a three day course of azithromycin in moderately severe community-acquired pneumonia. , 1995, The European respiratory journal.
[6] A. Camm,et al. Increased monocyte tissue factor expression in coronary disease. , 1995, British heart journal.
[7] D. Strachan,et al. Fibrinogen: a link between chronic infection and coronary heart disease , 1994, The Lancet.
[8] A. Folsom,et al. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators. , 1993, The American journal of medicine.
[9] H. Whittle,et al. Randomised controlled trial of single-dose azithromycin in treatment of trachoma , 1993, The Lancet.
[10] H. Fukushi,et al. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. , 1993, The Journal of infectious diseases.
[11] Qingbo Xu,et al. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis , 1993, The Lancet.
[12] D. Siscovick,et al. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. , 1992, JAMA.
[13] M. Leinonen,et al. Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study , 1992, Annals of Internal Medicine.
[14] S. Hopkins. Clinical toleration and safety of azithromycin. , 1991, The American journal of medicine.
[15] G. Foulds,et al. The pharmacokinetics of azithromycin in human serum and tissues. , 1990, The Journal of antimicrobial chemotherapy.
[16] M. Nieminen,et al. SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTION , 1988, The Lancet.
[17] R. Ross. The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.